Advanced search
Publication Cover
OncoTargets and Therapy Volume 10, 2017 - Issue
Submit an article Journal homepage
40
Views
5
CrossRef citations to date
0
Altmetric
Original Research

MDM2 promoter del1518 polymorphism and cancer risk: evidence from 22,931 subjects

Wenfeng Hua1 Department of Laboratory Medicine and Central Laboratories, Guangdong Second Provincial General Hospital, Guangzhou, GuangdongCorrespondence[email protected] [email protected]
,
Anqi Zhang2 Department of Obstetrics and Gynecology, The Second Affiliated Hospital & Yuying Children’s Hospital, Wenzhou Medical University, Wenzhou, Zhejiang
,
Ping Duan2 Department of Obstetrics and Gynecology, The Second Affiliated Hospital & Yuying Children’s Hospital, Wenzhou Medical University, Wenzhou, Zhejiang
,
Jinhong Zhu3 Molecular Epidemiology Laboratory and Department of Laboratory Medicine, Harbin Medical University Cancer Hospital, Harbin, Heilongjiang
,
Yuan Zhao2 Department of Obstetrics and Gynecology, The Second Affiliated Hospital & Yuying Children’s Hospital, Wenzhou Medical University, Wenzhou, Zhejiang
,
Jing He4 Department of Pediatric Surgery, Guangzhou Institute of Pediatrics, Guangzhou Women and Children’s Medical Center, Guangzhou Medical University, Guangzhou, Guangdong, People’s Republic of China
&
Zhi Zhang1 Department of Laboratory Medicine and Central Laboratories, Guangdong Second Provincial General Hospital, Guangzhou, GuangdongCorrespondence[email protected] [email protected]
 show all
Pages 3773-3780 | Published online: 27 Jul 2017

Citations (5)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Reham Helwa, Liv B. Gansmo, Merete Bjørnslett, Mari Kyllesø Halle, Henrica M. J. Werner, Pål Romundstad, Kristian Hveem, Lars Vatten, Anne Dørum, Per E. Lønning & Stian Knappskog. (2021) Impact of MDM2 promoter SNP55 (rs2870820) on risk of endometrial and ovarian cancer. Biomarkers 26:4, pages 302-308.
Read now

Articles from other publishers (4)

Amin Jalilvand, Kheirollah Yari, Mozaffar Aznab, Zohreh Rahimi, Iman Salahshouri Far & Pantea Mohammadi. (2020) A case‐control study on the SNP309T → G and 40‐bp Del1518 of the MDM2 gene and a systematic review for MDM2 polymorphisms in the patients with breast cancer . Journal of Clinical Laboratory Analysis 34:12.
Crossref
Heidi Miedl, Bianca Dietrich, Klaus Kaserer & Martin Schreiber. (2020) The 40bp Indel Polymorphism rs150550023 in the MDM2 Promoter is Associated with Intriguing Shifts in Gene Expression in the p53-MDM2 Regulatory Hub. Cancers 12:11, pages 3363.
Crossref
Florin Tripon, Mihaela Iancu, Adrian Trifa, George Andrei Crauciuc, Alina Boglis, Beata Balla, Adriana Cosma, Delia Dima, Marcela Candea, Erzsebet Lazar, Laura Jimbu & Claudia Banescu. (2020) Association Analysis of TP53 rs1042522, MDM2 rs2279744, rs3730485, MDM4 rs4245739 Variants and Acute Myeloid Leukemia Susceptibility, Risk Stratification Scores, and Clinical Features: An Exploratory Study. Journal of Clinical Medicine 9:6, pages 1672.
Crossref
Yosra Maleki, Zahra Alahbakhshi, Zahra Heidari, Mohammad‑Taher Moradi, Ziba Rahimi, Kheirolah Yari, Zohreh Rahimi, Mozafar Aznab, Meisam Ahmadi‑Khajevand & Fariborz Bahremand. (2019) NOTCH1, SF3B1, MDM2 and MYD88 mutations in patients with chronic lymphocytic leukemia. Oncology Letters.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.